LMNL — Liminal BioSciences Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $27.62m
- $14.21m
- CA$0.40m
Brief: Liminal Biosciences Reports Fourth Quarter And Year End 2020 Financial Results
Brief: Liminal Biosciences Provides Update On Business Strategy And Focus On Small Molecule Therapeutics
U.S. STOCKS ON THE MOVE-General Motors, Tesla, Gas stocks, Plug Power
U.S. STOCKS ON THE MOVE-fuboTV, ArcLight, Liminal BioSciences, Biomerica
Liminal BioSciences: Up on FDA approval for U.S. plasma collection center
Brief: Liminal Biosciences Receives FDA Approval For Its U.S.-Based Plasma Collection Center
Brief: Liminal Biosciences Announces First Subject Dosed In Phase 1 Clinical Trial Of Fezagepras
Brief: Liminal Biosciences Files Prospectus Related To Resale By Selling Shareholders Of Up To 20.2 Mln Shares
Brief: Liminal Biosciences Inc Files Prospectus Related To The Resale By Selling Shareholders Of Up To 14.2 Mln Shares
Brief: Liminal Biosciences Files For Mixed Shelf Of Up To $200 Mln
Brief: Liminal BioSciences Reports Third Quarter Financial Results
Brief: Liminal Biosciences Announces FDA Extension Of Review Period For Ryplazim BLA
Brief: Liminal Biosciences Announces Private Placement Financing Of $30 Million
U.S. STOCKS ON THE MOVE-Ichor Holdings Ltd, Roku Inc, Beyond Meat Inc, Universal Health Services Inc
U.S. STOCKS ON THE MOVE-Tapestry Inc, Cubic Corp, Adicet Bio Inc, HCA Healthcare Inc
Liminal BioSciences: Jumps as FDA to review license application for genetic disorder drug
Brief: Liminal BioSciences Provides Update On Progress On BLA For Ryplazim
Brief: Liminal Announces Resubmission Of Biologics License Application To U.S. FDA For Ryplazim
Brief: Liminal Biosciences Announces New Appointments To Its Board Of Directors